Polymorphic crystalline forms of celecoxib
Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory compound of low water solubility in a therapeutically effective amount, wherein the compound is present in the form of solid particles, about 25% to...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
04.05.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!